Immunomodulatory effects of selected cyanobacterial peptides in vitro
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F18%3A00101600" target="_blank" >RIV/00216224:14310/18:00101600 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61388971:_____/18:00491690
Výsledek na webu
<a href="https://www.sciencedirect.com/science/article/pii/S0041010118301740" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0041010118301740</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.toxicon.2018.04.031" target="_blank" >10.1016/j.toxicon.2018.04.031</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Immunomodulatory effects of selected cyanobacterial peptides in vitro
Popis výsledku v původním jazyce
Cyanobacteria produce many biologically active metabolites synthesized via nonribosomal synthetic pathways such as cyclic microcystins (MCs) and linear aeruginosins (Aers). The present study aimed to investigate the effects of different MC variants and the newly isolated aerugenosin Aer-865 on macrophages, which represent one of the key effector cells within the innate immune responses. Specifically, our study included RAW 264.7 macrophage activation associated with production of cytotoxic and cytostatic nitric oxide (NO) as well as pro-inflammatory mediators like tumor necrosis factor alpha (TNF alpha) and interleukin 6 (IL-6). From the compounds investigated, commonly occurring MC variants (-RR,-YR) and Aer-865 had no significant effects within the non-cytotoxic concentrations tested, i.e. 0.001-1 mu M for MCs and 0.1-50 mu M for Aer-865. In contrast to known immunoactive MC-LR, the negligible immunomodulatory potential of tested MC congeners could be related to their differences in structure. The knowledge of MC structure-specific activities contributes to the understanding of complex toxicity of different MC variants and most importantly their mixtures. This study is one of the first study that evaluate the effect of larger set of cyanobacterial peptides on macrophages and compare their immunomodulatory potential.
Název v anglickém jazyce
Immunomodulatory effects of selected cyanobacterial peptides in vitro
Popis výsledku anglicky
Cyanobacteria produce many biologically active metabolites synthesized via nonribosomal synthetic pathways such as cyclic microcystins (MCs) and linear aeruginosins (Aers). The present study aimed to investigate the effects of different MC variants and the newly isolated aerugenosin Aer-865 on macrophages, which represent one of the key effector cells within the innate immune responses. Specifically, our study included RAW 264.7 macrophage activation associated with production of cytotoxic and cytostatic nitric oxide (NO) as well as pro-inflammatory mediators like tumor necrosis factor alpha (TNF alpha) and interleukin 6 (IL-6). From the compounds investigated, commonly occurring MC variants (-RR,-YR) and Aer-865 had no significant effects within the non-cytotoxic concentrations tested, i.e. 0.001-1 mu M for MCs and 0.1-50 mu M for Aer-865. In contrast to known immunoactive MC-LR, the negligible immunomodulatory potential of tested MC congeners could be related to their differences in structure. The knowledge of MC structure-specific activities contributes to the understanding of complex toxicity of different MC variants and most importantly their mixtures. This study is one of the first study that evaluate the effect of larger set of cyanobacterial peptides on macrophages and compare their immunomodulatory potential.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30104 - Pharmacology and pharmacy
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2018
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Toxicon
ISSN
0041-0101
e-ISSN
—
Svazek periodika
149
Číslo periodika v rámci svazku
July
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
6
Strana od-do
20-25
Kód UT WoS článku
000436917900003
EID výsledku v databázi Scopus
—